Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04772846 | Chloroquine for Glioblastoma. | unknown | Phase 1 / Phase 2 | 60 | Egyptian Medical SyndicateOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04390802 | A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas | unknown | — | 40 | Massachusetts General HospitalOTHER | 0 | Feb 24, 2021 | clinicaltrials |
| NCT04216537 |
| Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas |
| unknown |
| — |
| 3,000 |
| The First Affiliated Hospital of Zhengzhou UniversityOTHER |
| 1 |
| Feb 8, 2021 |
| clinicaltrials |
| NCT04216550 | Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas | unknown | — | 600 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04220424 | Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis | unknown | — | 500 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03941626 | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies | unknown | Phase 1 / Phase 2 | 50 | Shenzhen BinDeBio Ltd.INDUSTRY | 1 | Feb 4, 2021 | clinicaltrials |
| NCT03258021 | TTFields In GErmany in Routine Clinical Care(TIGER) | unknown | — | 710 | NovoCure Ltd.INDUSTRY | 1 | Jan 28, 2021 | clinicaltrials |
| NCT02904525 | Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model(XENOGBM) | unknown | N/A | 20 | Andreas HottingerOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04386642 | Tranexamic Acid Reduce Blood Loss in Meningioma Resection | unknown | Phase 4 | 44 | Chiang Mai UniversityOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04588454 | 18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme(PSMA-GBM) | unknown | N/A | 5 | Radboud University Medical CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04725214 | Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma | unknown | Phase 2 | 33 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04717999 | Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma | unknown | N/A | 20 | UWELL BiopharmaINDUSTRY | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04715620 | Niraparib Combined With Radiotherapy in rGBM | unknown | Phase 2 | 30 | Tianjin Huanhu HospitalOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04706338 | Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction.(ATM) | unknown | N/A | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 14, 2021 | clinicaltrials |
| NCT04710485 | Sphenoorbital Meningioma Management. | unknown | — | 24 | Assiut UniversityOTHER | 0 | Jan 14, 2021 | clinicaltrials |
| NCT04675008 | Central Nervous System(CNS) Efficacy of Dacomitinib | unknown | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT00418899 | Gliogene: Brain Tumor Linkage Study | unknown | — | 17,080 | M.D. Anderson Cancer CenterOTHER | 6 | Dec 31, 2020 | clinicaltrials |
| NCT00498719 | Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer | unknown | — | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04689087 | A Prospective, Open-label, Single-arm Clinical Study | unknown | N/A | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04689321 | Revision of the EORTC QLQ-BN20 Questionnaire(QLQBN20) | unknown | — | 135 | Leiden University Medical CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04674527 | Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma | unknown | Phase 2 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT04674579 | Automatic Segmentation MRI Cerebral Glioma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Dec 19, 2020 | clinicaltrials |
| NCT04671368 | Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology | unknown | N/A | 141 | Jinsong WuOTHER | 0 | Dec 17, 2020 | clinicaltrials |
| NCT04668508 | Anlotinib to Malignant Brainstem Glioma | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04583020 | Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma | unknown | Phase 2 | 42 | Peking Union Medical College HospitalOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT04174820 | Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition(CervIRM) | unknown | — | 145 | University Hospital, AngersOTHER_GOV | 1 | Nov 19, 2020 | clinicaltrials |
| NCT03980431 | FBY PET/CT in Patients With Brain Tumors | unknown | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT04626206 | Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases(METRE) | unknown | — | 12 | Royal Marsden NHS Foundation TrustOTHER | 0 | Nov 12, 2020 | clinicaltrials |
| NCT04621565 | Hydrocortisone Use During Peri-operation for Pituitary Adenomas | unknown | N/A | 436 | Peking Union Medical College HospitalOTHER | 1 | Nov 9, 2020 | clinicaltrials |
| NCT04611685 | Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas | unknown | N/A | 202 | Peking Union Medical College HospitalOTHER | 1 | Nov 3, 2020 | clinicaltrials |
| NCT03569995 | [CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma | unknown | Phase 2 | 35 | Won Seog KimOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT04457869 | A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL) | unknown | Phase 2 | 43 | Shandong New Time Pharmaceutical Co., LTDINDUSTRY | 0 | Oct 22, 2020 | clinicaltrials |
| NCT04588987 | Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT03903419 | Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients(PAraDiGM) | unknown | N/A | 16 | Centre Leon BerardOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT04018963 | The Impact of Endoscopic Pituitary Surgery on Nasal Function | unknown | — | 100 | Zhebao WuOTHER | 1 | Oct 9, 2020 | clinicaltrials |
| NCT02239952 | HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) | unknown | N/A | 15 | Amsterdam UMC, location VUmcOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03463733 | Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)(HUTMZ) | unknown | Phase 1 | 54 | M.E. van LindeOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04562077 | Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome | unknown | — | 25 | Assiut UniversityOTHER | 1 | Sep 24, 2020 | clinicaltrials |
| NCT04550663 | NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors | unknown | Phase 1 | 10 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT04552977 | A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma | unknown | Phase 2 | 50 | Shandong Cancer Hospital and InstituteOTHER | 0 | Sep 17, 2020 | clinicaltrials |
| NCT04547621 | HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM(HSCK-010) | unknown | Phase 1 / Phase 2 | 50 | Huashan HospitalOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04547855 | Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen | unknown | Phase 2 | 54 | Yonggao MouOTHER | 1 | Sep 14, 2020 | clinicaltrials |
| NCT01567202 | Study of DC Vaccination Against Glioblastoma | unknown | Phase 2 | 100 | Huashan HospitalOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT02756312 | The Impact of Anesthesia on High- Grade Glioma Patients | unknown | N/A | 196 | Beijing Tiantan HospitalOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04536649 | Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma. | unknown | Phase 3 | 369 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT04529356 | The TMS Treatment for Postoperative Headache in GH Tumor | unknown | N/A | 200 | Huashan HospitalOTHER | 0 | Aug 27, 2020 | clinicaltrials |
| NCT04516655 | A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients(C-R-HDMTX) | unknown | Phase 2 | 51 | Fudan UniversityOTHER | 0 | Aug 18, 2020 | clinicaltrials |
| NCT04517019 | Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy(OnkoFit II) | unknown | N/A | 201 | University Hospital TuebingenOTHER | 1 | Aug 18, 2020 | clinicaltrials |
| NCT04490954 | The Accuracy of Brain Biological Electrical Impedance Tomography Screen for Supratentorial Tumors(ABST) | unknown | N/A | 46 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 29, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Feb 26, 2021source: clinicaltrials